Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 75 | +20 |
| Shares | 14.3M | 400 | 25.3M | +11.0M (+76.9%) |
| Value | $16.9M | $468 | $30.4M | +$13.5M (+79.6%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (10)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wealth Advisory Solutions, LLC | 155,850 | $182.3K |
| Man Group plc | – | $155.4K |
| Qube Research & Technologies Ltd | 100,106 | $117.1K |
| Boothbay Fund Management, LLC | 75,188 | $88.0K |
| Squarepoint Ops LLC | 73,513 | $86.0K |
| Jump Financial, LLC | 66,143 | $77.4K |
| Group One Trading, L.P. | 48,895 | $57.2K |
| Lighthouse Investment Partners, LLC | 36,126 | $42.3K |
| Y-Intercept (Hong Kong) Ltd | 10,603 | $12.4K |
| Syverson Strege & Co | 2,145 | $2.51K |
Not filed for Q2 2023 yet (1)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Clear Perspectives Financial Planning, LLC | 400 | $468 |